GB0127132D0 - Assay - Google Patents
AssayInfo
- Publication number
- GB0127132D0 GB0127132D0 GBGB0127132.9A GB0127132A GB0127132D0 GB 0127132 D0 GB0127132 D0 GB 0127132D0 GB 0127132 A GB0127132 A GB 0127132A GB 0127132 D0 GB0127132 D0 GB 0127132D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- assay
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0127132A GB2381866A (en) | 2001-11-12 | 2001-11-12 | Assays for liver X receptor (LXR) modulators |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0127132A GB2381866A (en) | 2001-11-12 | 2001-11-12 | Assays for liver X receptor (LXR) modulators |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0127132D0 true GB0127132D0 (en) | 2002-01-02 |
GB2381866A GB2381866A (en) | 2003-05-14 |
Family
ID=9925618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0127132A Withdrawn GB2381866A (en) | 2001-11-12 | 2001-11-12 | Assays for liver X receptor (LXR) modulators |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2381866A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023240376A1 (en) * | 2022-06-12 | 2023-12-21 | 中国医学科学院药物研究所 | Use of intestinal epithelial cell nuclear receptor repressor ncor as target in drug screening |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050036992A1 (en) * | 2002-12-23 | 2005-02-17 | Irm Llc | Novel use of liver X receptor agonists |
WO2006077012A2 (en) * | 2005-01-18 | 2006-07-27 | Genfit S.A. | USE OF LXR LIGANDS FOR THE MODULATION OF DENDRITIC CELLS (DCs) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7101681B1 (en) * | 1997-11-21 | 2006-09-05 | Amgen, Inc. | Nuclear hormone receptor drug screens |
US6316503B1 (en) * | 1999-03-15 | 2001-11-13 | Tularik Inc. | LXR modulators |
EP1212065A4 (en) * | 1999-07-08 | 2004-02-11 | Tularik Inc | Compositions and methods for raising hdl cholesterol levels |
EP1210345B1 (en) * | 1999-09-08 | 2004-03-03 | Glaxo Group Limited | Oxazole ppar antagonists |
EP1239855A4 (en) * | 1999-12-13 | 2004-04-21 | Merck & Co Inc | Method for the prevention and/or treatment of atherosclerosis |
WO2001060818A1 (en) * | 2000-02-14 | 2001-08-23 | Tularik Inc. | Lxr modulators |
US6673543B2 (en) * | 2000-04-05 | 2004-01-06 | Tularik, Inc. | Solid phase synthesis of LXR ligands |
US20020048572A1 (en) * | 2000-05-03 | 2002-04-25 | Bei Shan | Treatment of hypertriglyceridemia and other conditions using LXR modulators |
BR0111688A (en) * | 2000-06-13 | 2004-02-17 | Univ Arkansas | Methods of dissociation of non-genotropic activity from steroid receptor genotropic activity |
GB0019290D0 (en) * | 2000-08-04 | 2000-09-27 | Symphar Sa | Methods for inducing apolipoprotein E secretion |
-
2001
- 2001-11-12 GB GB0127132A patent/GB2381866A/en not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023240376A1 (en) * | 2022-06-12 | 2023-12-21 | 中国医学科学院药物研究所 | Use of intestinal epithelial cell nuclear receptor repressor ncor as target in drug screening |
Also Published As
Publication number | Publication date |
---|---|
GB2381866A (en) | 2003-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0303809A3 (en) | Assay system | |
GB0120126D0 (en) | Assay device | |
EP1442299A4 (en) | Assay | |
EP1470421A4 (en) | Rapid prion-detection assay | |
GB0115777D0 (en) | Assay | |
GB0012860D0 (en) | Assay | |
PL370539A1 (en) | Assay | |
GB0008784D0 (en) | Assay | |
GB0101313D0 (en) | Assay | |
GB0120589D0 (en) | Assay | |
GB0121440D0 (en) | Assay | |
GB0005894D0 (en) | Assay | |
GB0003902D0 (en) | Assay | |
GB0127132D0 (en) | Assay | |
GB0010960D0 (en) | Assay | |
GB0100782D0 (en) | Assay | |
GB0101312D0 (en) | Assay | |
GB0001703D0 (en) | Assay | |
GB0100290D0 (en) | Assay | |
GB0105362D0 (en) | Assay | |
GB0003898D0 (en) | Assay | |
GB0013561D0 (en) | Assay | |
GB0023239D0 (en) | Assay | |
GB0019242D0 (en) | Assay | |
GB0130958D0 (en) | Assay |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |